Optejet (device for instilling drugs in the eyes)

2022: Device Announcement

In mid-December 2022, the American company Eyenovia presented a new device for comfortable and effective delivery of drugs to patients' eyes. The compact electronic device is called Optejet.

It uses high-precision Microdose Array Print (MAP) technology, which provides for spraying the drug in the form of a directed fog with an array of microdroplets. Eyenovia compares the principle of operation of the MAP system with an inkjet printer: the medicine covers the surface of the cornea of ​ ​ the eye like pixels. In this case, about 6-8 μl of the drug is delivered against 40 μl, which are usually injected with standard tools. This eliminates the possibility of overspending the drug, which can be very expensive. In addition, the likelihood of tear and side effects due to an overdose of the drug is reduced.

Optejet (device for instilling drugs in the eyes)

To use Optejet, just bring the device to the eye and press the button. The solution is injected in about 80 milliseconds, ahead of the blink reflex. In this case, the contact of microdroplets with the cornea occurs at a low speed, which minimizes the effect on the eyes and eliminates discomfort. You can use the device with convenience both sitting and standing.

The Optejet device is capable of communicating with a smartphone. The mobile application allows you to monitor and receive notifications about the introduction of the following doses of the drug product. The accumulated information can be remotely shared with the doctor to obtain timely recommendations for optimizing the course of therapy.

Eyenovia's patented device uses a new approach to administering eye drugs through microdosing and does so in a way that improves patient experience, "said Michael Rowe, CEO of Eyenovia.[1]

Notes